PrECOG Cancer Research Group

PrECOG Cancer Research Group Innovative cancer research studies developed through industry partnerships and networks.

Supporting ECOG-ACRIN Cancer Research Group's efforts to advance cancer care

How well does osimertinib—with or without chemotherapy—work to control EGFR-positive Lung Cancer in patients not partici...
10/14/2025

How well does osimertinib—with or without chemotherapy—work to control EGFR-positive Lung Cancer in patients not participating in a clinical trial? The PrE1702 research study aims to find out. More: https://bit.ly/pre1702-study

The PrE1702 research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-posit...
10/07/2025

The PrE1702 research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-positive in patients not participating in a clinical trial. Learn more: https://bit.ly/pre1702-study

10/01/2025

We congratulate Dr. Anthony Letai on his appointment as National Cancer Institute Director. His deep scientific expertise & reputation as a collaborative leader make him an excellent choice to drive progress against . We look forward to working with him!

09/09/2025

We are collecting real world data alongside an ongoing phase 3 trial. By comparing treatment effects between & populations treated in routine care, we aim to bridge the “generalizability gap.” Read Dr. Suzanne Cole's article in The ASCO Post: https://bit.ly/Pre1702RWD

How well does osimertinib—with or without chemotherapy—work to control EGFR-positive in patients not participating in ...
08/19/2025

How well does osimertinib—with or without chemotherapy—work to control EGFR-positive in patients not participating in a clinical trial? The PrE1702 research study aims to find out. Learn more: https://bit.ly/pre1702-study

07/22/2025

Read more from our co-chairs on the importance of protecting public support for biomedical research: https://bit.ly/3IvxNQD

Address

1818 Market Street, Suite 3000
Philadelphia, PA
19118

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+12157897001

Website

Alerts

Be the first to know and let us send you an email when PrECOG Cancer Research Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

PrECOG, LLC develops and leads research that provides new hope for patients and their families. This is accomplished through innovation, working with oncology research leaders, partnerships with research groups, and collaborations with industry partners. Our goal is to design, implement, and publish results for clinical trials that support the ever-evolving needs of patients with cancer and our underlying knowledge of cancer diseases.